Market Currents
The FDA is expanding the approved use of Abbott's (ABT -1%) Humira to include treatment of...
-
Friday, September 28, 2012, 2:13 PM ETThe FDA is expanding the approved use of Abbott's (ABT -1%) Humira to include treatment of moderate-to-severe ulcerative colitis in adults, when immunosuppressant medicines have not worked. The drug is currently approved for use in reducing the signs and symptoms of rheumatoid arthritis.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
